BioCentury
ARTICLE | Clinical News

Pagoclone: Phase IIb start

February 2, 2009 8:00 AM UTC

This quarter, Indevus will begin a double-blind, placebo-controlled, U.S. Phase llb trial, with an open-label extension, in about 300 patients. Teva, which has an exclusive, worldwide license to the c...